AUTEN-67
AUTEN-67 is an autophagy-enhancing drug candidate that increases autophagic flux in cell lines and in vivo models.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
AUTEN-67 is an autophagy-enhancing drug candidate that increases autophagic flux in cell lines and in vivo models. It hampers the progression of neurodegenerative symptoms in a Drosophila model of Huntington's disease. It is developed by Velgene Biotechnology Ltd.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330122300 under CC BY-SA 4.0; modifications have been made.